> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Workshop on Model Informed Drug Development
- URL: https://www.fdaweb.com/workshop-on-model-informed-drug-development/
- Published: 2021-04-22T12:00:00.000Z
- Updated: 2026-09-14T16:55:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149166

*Federal Register* notice: FDA is announcing a 6/9 public workshop entitled “Model Informed Drug Development Approaches for Immunogenicity Assessments.” The workshop will discuss the best practices and future directions of quantitative methods for predicting biological product immunogenicity. It is also being conducted to satisfy one of FDA’s performance goals under the Prescription Drug User Fee Amendments related to model-informed drug development. To view the notice, click [here](https://public-inspection.federalregister.gov/2021-08487.pdf?ref=fdaweb.com).